IRVINE, Calif.--(BUSINESS WIRE)--Jan. 18, 2006--TRIMEDYNE, INC. (OTCBB:TMED) today reported a 4.7% increase in revenues to $1,699,000 for the quarter ended September 30, 2005, versus revenues of $1,623,000 for the same quarter of the prior year. Revenues for the year ended September 30, 2005, increased 8.5% to $6,482,000, from $5,973,000 in the prior year. In the current quarter, Trimedyne had a net profit, after income taxes, of only $190,000 or $0.01 per share, versus a net profit of $529,000 or $0.04 per share in the prior year quarter. Profit for the prior year quarter included the benefit of an adjustment to the Company’s inventory reserve of $290,000, and R & D costs in the current quarter increased by $92,000 from the prior year’s quarter.
